Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries
Table 1
Outcomes at each stage of HIV care.
% (95% CI)
Entry into care ()
<3 months
70.3 (69.2–71.3)
3–6 months
4.5 (4–5)
6–9 months
2 (1.7–2.4)
9–12 months
1.1 (0.9–1.4)
>12 months
3.8 (3.4–4.2)
No entry
18.4 (17.5–19.2)
Retention in pre-ART care ()
100%
26.3 (24.3–28.4)
75–99.9%
9 (7.7–10.5)
50–74.9%
23 (21.1–25.1)
<50%
12.7 (11.2–14.4)
0%
29 (26.8–31.2)
CD4 > 250 in the last year of followup
56 (53.6–58.3)
ART initiation ()
<3 months
67.3 (65.8–68.7)
3–6 months
4.6 (4–5.2)
6–9 months
2.3 (1.9–2.8)
9–12 months
0.9 (0.7–1.3)
>12 months
3.1 (2.6–3.6)
No ART initiation
21.9 (20.6–23.1)
Retention in ART care ()
Died
15.1 (13.9–16.4)
ART stopped
0.7 (0.5–1.1)
LTFU
15 (13.8–16.2)
Alive and on ART
69.2 (67.5–70.8)
Last viral load <400 c/mL ()
No
18.2 (16.6–20)
Yes
81.8 (80–83.4)
ART: antiretroviral therapy; CI: confidence interval; LTFU: lost to followup.
